Concept

Prostate-specific antigen

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. PSA is not uniquely an indicator of prostate cancer, but may also detect prostatitis or benign prostatic hyperplasia. Prostate cancer screening Clinical practice guidelines for prostate cancer screening vary and are controversial, in part due to uncertainty as to whether the benefits of screening ultimately outweigh the risks of overdiagnosis and overtreatment. In the United States, the Food and Drug Administration (FDA) has approved the PSA test for annual screening of prostate cancer in men of age 50 and older. The patient is required to be informed of the risks and benefits of PSA testing prior to performing the test. In the United Kingdom, the National Health Service (NHS) does not mandate, nor advise for PSA test, but allows patients to decide based on their doctor's advice. The NHS does not offer general PSA screening, for similar reasons. PSA levels between 4 and 10 ng/mL (nanograms per milliliter) are considered to be suspicious, and consideration should be given to confirming the abnormal PSA with a repeat test. If indicated, prostate biopsy is performed to obtain a tissue sample for histopathological analysis. While PSA testing may help 1 in 1,000 avoid death due to prostate cancer, 4 to 5 in 1,000 would die from prostate cancer after 10 years even with screening. This means that PSA screening may reduce mortality from prostate cancer by up to 25%.

Official source

https://en.wikipedia.org/wiki/Prostate-specific_antigen

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related courses (2)

BIO-320: Morphology I

Ce cours est une préparation intensive à l'examen d'entrée en 3ème année de Médecine. Les matières enseignées sont la morphologie macroscopique (anatomie), microscopique (histologie) du corps humain. La matière est présentée dans une perspective médicale s ...

BIOENG-399: Immunoengineering

Immunoengineering is an emerging field where engineering principles are grounded in immunology. This course provides students a broad overview of how engineering approaches can be utilized to study immunology, model immune systems, modulate immune response ...

Related lectures (6)

Causal Inference in Epidemiology: Pregnancy and Prostate Cancer

Explores causal inference in epidemiology, focusing on COVID-19's impact on preterm birth and refining treatment strategies for prostate cancer.

Male Reproductive System Anatomy

Explains the male reproductive system anatomy, including vas deferens, prostate, and seminal vesicles.

Urinary System Anatomy

Explores the anatomy of the urinary system, focusing on the renal structures, ureters, bladder, and urethra.

Related publications (13)

Multi-mode CMOS Implementation of Prostate Cancer Diagnostics with In-memory Sensing and Edge Computing

This paper proposes a novel 180 nm CMOS implementation of a device for a direct prostate cancer risk computation based on the simultaneous measurement and analysis of Prostate Specific Antigen (PSA) and its membrane isoform (PSMA) using in-memory sensing and computing. A comprehensive performance evaluation was performed by considering a stimulation period of 1 s, including post-layout extraction (PEX) simulations and process corner variations. The circuit was tested with the antigen concentrations of up to

IEEE2026

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [ 68 Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer

Ga]Ga-OncoACP3-DOTA demonstrated favorable pharmacokinetics with increasing tumor uptake and tumor-to-background ratios at later time points, suggesting potential benefits for delayed imaging, especially with high-sensitive PET systems or radiolabeling with isotopes with longer half-lives. The dosimetry profile was favorable, with a lower effective dose compared with many prostate-specific membrane antigen-targeted radiopharmaceuticals and negligible salivary gland uptake, potentially reducing side effects

Society of Nuclear Medicine2026

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis

Prostate cancer is a growing global health challenge. To identify new ways to improve patient care, researchers need a variety of preclinical models that faithfully recapitulate human tumours across the disease continuum, from initiation to metastasis. These complementary models include primary cultures of prostate epithelial cells (PrECs), co-cultures, patient-derived explants (PDEs), patient-derived organoids (PDOs) and patient-derived xenografts (PDXs). Collectively, these models enable researchers to st

Elsevier BV2026

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Official source

https://en.wikipedia.org/wiki/Prostate-specific_antigen

About this result

Related courses (2)

BIO-320: Morphology I

BIOENG-399: Immunoengineering

Related lectures (6)

Causal Inference in Epidemiology: Pregnancy and Prostate Cancer

Explores causal inference in epidemiology, focusing on COVID-19's impact on preterm birth and refining treatment strategies for prostate cancer.

Male Reproductive System Anatomy

Explains the male reproductive system anatomy, including vas deferens, prostate, and seminal vesicles.

Urinary System Anatomy

Explores the anatomy of the urinary system, focusing on the renal structures, ureters, bladder, and urethra.

Related publications (13)

Multi-mode CMOS Implementation of Prostate Cancer Diagnostics with In-memory Sensing and Edge Computing

IEEE2026

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [ 68 Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer

Society of Nuclear Medicine2026

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis

Elsevier BV2026

Related people (11)

Giovanni De Micheli

Expertise Design technologies for integrated systems on silicon, such as synthesis, hw/sw codesign and low-power design, as well as systems on heterogeneous platforms including electrical and biological components. Scientific Director of EcoCloud Center at EPFL Directing activities towards creating sustainable computation including AI.Designing energy-savvy data centers and edge devices. More information Please read http://si2.epfl.ch/~demichel/ Giovanni De Micheli is a research scientist in electronics and

Nathalie Just

Expertise OncologyMRI, fMRI, fMRS, Diffusion MRS,Animal ModelsAnimal physiologyOptogenetics, Chemogenetics Current work -Functional magnetic Resonance imaging in rats and mice -Manganese-enhanced MRI: High Resolution MR Imaging -Functional MR Spectroscopy in small animals - New contrasts for MRI and MRS Mission I am interested in all functional aspects of normal and diseased brain from neural activity to metabolism. -2011-present: EPFL-CIBM AIT Core - Responsible for MR Imaging developments and applications

Junrui Chen

Junrui Chen achieved his BSc. degree in Mechanism and its automation from Beihang University (BUAA), Beijing, China in 2017. Meanwhile, he also received a second degree in Business administration and management. He completed his MSc in Mechatronics and Information Technology at Karlsruhe Institute of Technology (KIT), Germany, in 2021. During his master's studies, he participated in a project at the Institute of Biomedical Engineering (BIT) to optimize an interface for ECG/PLT signal detection using MATLAB

Cristina Ramona Cudalbu Moldovan

Cristina Cudalbu obtained her Bachelors of Science degree in Medical Physics in 2002 and Masters of Science degree in Biophysics and Medical Physics in 2003, both from University Babes-Bolyai, Cluj-Napoca, Romania. In 2006 she obtained her PhD degree in Localized Proton MRS and time domain quantification of cerebral metabolites at 7T and 4.7T at University Lyon 1, RMN Laboratory, Villeurbanne, France.In 2007, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented new acquisition and quantification techniques for in vivo nitrogen, proton and carbon MRS for preclinical studies. Starting 2012, Cristina Cudalbu was appointed as Research Staff Scientist and 9.4T MRI Operational Manager at Centre d’Imagerie Biomédicale (CIBM) at EPFL. She is now developing new research lines at CIBM, being oriented towards new acquisition and quantification techniques for in vivo proton, phosphorous, carbon, nitrogen MRS and fast MRSI, diffusion weighted spectroscopy and brain macromolecules quantification. She is now applying these developments on chronic hepatic encephalopathy, a research area that she developed at CIBM (https://actu.epfl.ch/news/when-liver-disease-affects-the-brain/), and on different collaborative projects with researchers from the five partner institutions of CIBM.

Rolf Gruetter

Awards: 1999 Young Investigator Award Plenary Lectureship , International Society for Neurochemistry 2011 Fellow , ESMRMB 2011 Teaching Award , Section Sciences de la Vie, EPFL

Alireza Mafi

Expertise Electromagnetics TheoryAntennas & MicrowavesRadio Frequency Integrated CircuitsPhased ArraysBioelectronics Expertise Electromagnetics TheoryAntennas & MicrowavesRadio Frequency Integrated CircuitsPhased ArraysBioelectronics I am a PhD student in Electrical Engineering at the école Polytechnique Fédérale de Lausanne (EPFL). I received my M.Sc. in Electrical Engineering (Microwave and Optical Communications) from the Sharif University of Technology, Tehran, Iran in 2022. I also worked at ETH Zurich

Mats Julius Stensrud

Teaching & PhD PhD Students Ignacio Gonzalez Perez, Gellért Géza Perényi, Lorenzo Gasparollo, Julien David Laurendeau Past EPFL PhD Students Matias Janvin, Amit Sawant Courses Causal thinking MATH-352 This course will give a unified presentation of modern methods for causal inference. We focus on concepts, and we will present examples and ideas from various scientific disciplines, including medicine, computer science, engineering, economics and epidemiology. Probability and statistics (

Thomas La Grange

Expertise Electron Microscopy, Aberration Correct Scanning Transmission Electron Microscopy, Electron Diffraction, Ultrafast Transmission Electron Microscopy, Electron Energy Loss Spectroscopy, Energy Dispersive Spectroscopy, Materials Science, High-speed deformation, Dislocation Dynamics, Skyrmionics, Martensitic Phase Transformation Theory, Solidification Expertise Electron Microscopy, Aberration Correct Scanning Transmission Electron Microscopy, Electron Diffraction, Ultrafast Transmission Electron Micro

Hubert Girault

Education: 1979 - Engineering diploma from Grenoble Institute of Technology. FRANCE. 1982 - PhD- Department of Chemistry, University of Southampton. Thesis entitled : Interfacial studies using drop image processing techniques. Positions : 1982 - 1984 SERC Research Fellow. University of Southampton. 1984 - 1985 CNRS Research Fellow. University of Southampton. 1985 - 1992 Lecturer in Physical Chemistry, University of Edinburgh. 1992 - Professor of Physical Chemistry, Ecole Polytechnique Fédérale de Lausanne. 2011 - 2014 Dean of Bachelor and Master studies Hubert Girault is the author of 2 textbooks, the co-author of about 600 scientific publications with more than 20'000 citations and the co-inventor of more than 15 patents. During his academic career, he has supervised 70 PhD students. 30 alumni of his laboratory are now Professors. Honours: Faraday medal 2006, Royal Society of Chemistry, Fellow of the International Society of Electrochemistry 2007, Reilley Award 2015. Fellow of the Electrochemical Society (USA), Shikata International medal, Polarography Society of Japan. Associate editor of Chemical Science

Wouter Richard Karthaus

Teaching & PhD PhD Students Jillian Rose Love, Estelle Deby, Ester Simkova, Turan Badalli Courses Cellular and molecular biology II BIO-207 This course is aimed to familiarize students with the 3D organization of a eukaryotic cell, its compartmentalization, how cellular compartments communicate together and how a cell communicates with its environment. The related molecular mechanisms will be discussed. Practical - Karthaus Lab BIO-616 Students will learn 1) how organoids c

Related units (5)

SCI STI SC Group

IEL - Administration

Integrated Circuits Laboratory

Related concepts (5)

Rectal examination

Digital rectal examination (DRE), also known as a prostate exam (palpatio per anum (PPA)), is an internal examination of the rectum performed by a healthcare provider. Prior to a 2018 report from the United States Preventive Services Task Force, a digital exam was a common component of annual exams for older men, as it was thought to be a reliable screening test for prostate cancer. This examination may be used: for the diagnosis of prostatic disorders, benign prostatic hyperplasia and the four types of prostatitis.

Prostate biopsy

Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined for the presence of prostate cancer. It is typically performed when the result from a PSA blood test is high. It may also be considered advisable after a digital rectal exam (DRE) finds possible abnormality. PSA screening is controversial as PSA may become elevated due to non-cancerous conditions such as benign prostatic hyperplasia (BPH), by infection, or by manipulation of the prostate during surgery or catheterization.

Biomarker

In biomedical contexts, a biomarker, or biological marker, is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated using blood, urine, or soft tissues to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields. Biomarker (medicine)Biomarkers used in the medical field, are a part of a relatively new clinical toolset categorized by their clinical applications.